Park State Asset Management Has $5.71 Million Stake in Align Technology, Inc. $ALGN

Park State Asset Management increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 22.1% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,333 shares of the medical equipment provider’s stock after acquiring an additional 6,024 shares during the quarter. Align Technology accounts for approximately 4.3% of Park State Asset Management’s portfolio, making the stock its 11th largest position. Park State Asset Management’s holdings in Align Technology were worth $5,714,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Bull Harbor Capital LLC acquired a new stake in Align Technology in the first quarter worth $710,000. California State Teachers Retirement System raised its holdings in shares of Align Technology by 21.2% during the first quarter. California State Teachers Retirement System now owns 79,293 shares of the medical equipment provider’s stock valued at $13,593,000 after purchasing an additional 13,867 shares during the period. Empowered Funds LLC boosted its position in shares of Align Technology by 279.0% during the 1st quarter. Empowered Funds LLC now owns 6,311 shares of the medical equipment provider’s stock worth $1,082,000 after purchasing an additional 4,646 shares in the last quarter. Quantinno Capital Management LP boosted its position in shares of Align Technology by 135.2% during the 1st quarter. Quantinno Capital Management LP now owns 112,859 shares of the medical equipment provider’s stock worth $19,347,000 after purchasing an additional 64,874 shares in the last quarter. Finally, SummitTX Capital L.P. acquired a new stake in shares of Align Technology in the 1st quarter valued at about $1,630,000. Institutional investors and hedge funds own 88.43% of the company’s stock.

Trending Headlines about Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations: Align reported adjusted earnings of $2.64 per share versus the $2.62 consensus estimate, while revenue reached approximately $1.06 billion, ahead of expectations and up 4.3% year over year. Non-GAAP margins also improved. Align Technology Announces Second Quarter 2026 Financial Results
• Positive Sentiment: Clear-aligner momentum remains strong: Record Invisalign shipments and continued expansion of digital workflows support Align’s core growth strategy. Management highlighted increased adoption of connected orthodontic tools and reaffirmed its 2026 outlook. ALGN Q2 Earnings Call Highlights Digital Growth Push
• Positive Sentiment: Board and strategic changes could enhance shareholder value: Align plans to add three independent directors and conduct an operational review following discussions with Elliott Investment Management. The initiatives may improve governance, efficiency and capital allocation. Align Technology to overhaul board following engagement with Elliott
• Neutral Sentiment: Digital orthodontics remains a long-term focus: At its 2026 Invisalign Ortho Summit, Align presented its “Beyond Possible” vision for connected digital orthodontics, emphasizing integration of Invisalign, iTero scanners and exocad software. The event reinforces the company’s strategy but provides limited immediate financial impact. Align Technology Hosts 2026 Invisalign Ortho Summit
• Negative Sentiment: Near-term concerns temper the earnings beat: Third-quarter revenue guidance was broadly in line but was viewed as slightly below some expectations. Investors are also monitoring scanner pricing pressure and weaker systems performance, which could limit revenue growth and offset clear-aligner strength. Needham maintained a Hold rating, citing capped near-term upside. Align Technology Hold Rating Maintained

Analysts Set New Price Targets

A number of analysts recently commented on the company. Weiss Ratings raised Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Evercore raised their price objective on Align Technology from $200.00 to $220.00 in a research note on Thursday, April 30th. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research note on Thursday. UBS Group restated a “neutral” rating and set a $189.00 price objective on shares of Align Technology in a report on Thursday, July 23rd. Finally, Morgan Stanley upped their target price on Align Technology from $169.00 to $188.00 and gave the stock an “equal weight” rating in a research report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $206.36.

Align Technology Stock Performance

Shares of ALGN opened at $173.41 on Friday. The firm has a market capitalization of $12.42 billion, a P/E ratio of 30.16, a P/E/G ratio of 1.85 and a beta of 1.67. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $200.43. The stock has a 50 day moving average price of $174.44 and a two-hundred day moving average price of $175.25.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.62 by $0.02. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Align Technology had a return on equity of 16.04% and a net margin of 9.99%.Align Technology’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.49 earnings per share. On average, equities analysts forecast that Align Technology, Inc. will post 9.48 earnings per share for the current year.

Align Technology announced that its Board of Directors has approved a stock buyback plan on Wednesday, April 29th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the medical equipment provider to buy up to 1.6% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.